Clinical Trial: A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V1)
Study Status: Completed
Recruit Status: RECRUITING
Condition: NonSegmental Vitiligo
Study Type: INTERVENTIONAL
Official Title: A Phase 3, Randomized, Double-Blind, 52-Week, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib in Participants With Nonsegmental Vitiligo
Brief Summary:
This study is being conducted to determine the efficacy and safety of povorcitinib in participants with nonsegmental vitiligo.
Read more